WallStreetZenWallStreetZen

NYSE: PBH
Prestige Consumer Healthcare Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PBH past earnings growth

How has PBH's earnings growth performed historically?
Company
N/A
Industry
26.66%
Market
53.07%
PBH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PBH's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

PBH past revenue growth

How has PBH's revenue growth performed historically?
Company
-1.49%
Industry
37.31%
Market
16.68%
PBH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PBH's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PBH's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PBH earnings and revenue history

Current Revenue
$1.1B
Current Earnings
$205.1M
Current Profit Margin
18.4%
PBH's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

PBH Return on Equity

Current Company
12.7%
Current Industry
11.7%
Current Market
34.1%
PBH's Return on Equity (12.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PBH announces earnings.

PBH Return on Assets

Current Company
6.2%
Current Industry
4.2%
PBH is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PBH Return on Capital Employed

Current Company
10.28%
Current Industry
11.6%
PBH has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PBH vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PBH$1.11B$366.17M$205.13M+3.14%+8.05%
PRGO$4.43B$295.20M-$124.50M-0.98%N/A
ALVO$308.73M-$154.42M-$618.38M+506.63%N/A
HCM$610.81MN/A-$41.97M+23.32%N/A
ALKS$1.51B$300.34M$288.72M+7.15%+183.61%
View Top Pharmaceutical Stocks

PBH earnings dates

Next earnings date
Oct 31, 2024

Prestige Consumer Healthcare Earnings & Revenue FAQ

What were PBH's earnings last quarter?

On Invalid Date, Prestige Consumer Healthcare (NYSE: PBH) reported Q2 2024 earnings per share (EPS) of $0.98, up 8.41% year over year. Total Prestige Consumer Healthcare earnings for the quarter were $49.07 million. In the same quarter last year, Prestige Consumer Healthcare's earnings per share (EPS) was $1.07.

If you're new to stock investing, here's how to buy Prestige Consumer Healthcare stock.

What was PBH's earnings growth in the past year?

As of Q3 2024, Prestige Consumer Healthcare's earnings has grown year over year. Prestige Consumer Healthcare's earnings in the past year totalled $205.13 million.

What is PBH's earnings date?

Prestige Consumer Healthcare's earnings date is Invalid Date. Add PBH to your watchlist to be reminded of PBH's next earnings announcement.

What was PBH's revenue last quarter?

On Invalid Date, Prestige Consumer Healthcare (NYSE: PBH) reported Q2 2024 revenue of $267.14 million up 4.36% year over year. In the same quarter last year, Prestige Consumer Healthcare's revenue was $279.31 million.

What was PBH's revenue growth in the past year?

As of Q3 2024, Prestige Consumer Healthcare's revenue has grown -1.49% year over year. This is 38.79 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 37.31%. Prestige Consumer Healthcare's revenue in the past year totalled $1.11 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.